UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 14, 2024
Accession Number:
0000950103-24-003773
Submission Type:
POS AM
CIK:
0001771910
Company Name:
ADC Therapeutics SA
File Number:
333-270570